News
Remdesivir sharply cuts COVID hospitalization risk, Gilead says
September 23, 2021
An RCT evaluated the efficacy and safety of a 3-day course of intravenous remdesivir in an analysis of 562 nonhospitalized patients at high risk for disease progression.
News
Nurses ‘at the breaking point,’ consider quitting due to COVID issues: Survey
September 21, 2021
“What we’re hearing from our nurses is really shocking.”
News
Doctors search for missing link between COVID-19 and ITP
January 28, 2021
“We don’t know much about platelet counts in COVID-19 at all.”
News
Even patients with cancer in remission at risk for severe COVID-19
January 26, 2021
Cancer patients, regardless of their age, and even if they are in remission, should be prioritized for vaccination against COVID-19.
![1]()
News
COVID-19 and risk of clotting: ‘Be proactive about prevention’
December 8, 2020
"We believe a systematic way of addressing this risk is best, with every patient hospitalized with COVID-19 receiving some type of thromboprophylaxis," authors of a review article say.
![1]()
News
What happened to melanoma care during COVID-19 sequestration
November 11, 2020
Preliminary evidence indicates delayed diagnosis and treatment measurably worsened outcome indicators.
News
Higher death rate seen in cancer patients with nosocomial COVID-19
July 30, 2020
All-cause mortality was higher in cancer patients with hospital-acquired COVID-19 than in those with community-acquired COVID-19.
![1]()
Opinion
Hematologic manifestations of COVID-19
July 29, 2020
Dr. Alan P. Lyss examines a review on extrapulmonary manifestations of COVID-19, focusing in on hematologic effects.
![1]()
Article
Endothelial injury may play a major role in COVID-19–associated coagulopathy
June 29, 2020
Dr. Alan P. Lyss reviews research suggesting endotheliopathy may be a marker of COVID-19 severity.
News
Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?
May 26, 2020
“The special attraction of this modality of treatment is that, unlike vaccines or newly developed drugs, it could, in principle, be made available very rapidly.”
